Technology powerhouse IBM (NYSE: IBM) has trailed the market for the better part of a decade now, even though the stock is holding up slightly better than the S&P 500 in 2020. The company reports first-quarter results early next week, so it's time to consider whether Big Blue is a good buy in the midst of the COVID-19 crisis.
The COVID-19 disease itself doesn't appear to threaten IBM's results in the near term. The company has not lowered its financial guidance targets, but IBM's press room is full packed with examples of how Big Blue is helping the world confront the virus.
Recently appointed CEO Arvind Krisha says that the pandemic will accelerate the adoption of cloud computing and artificial intelligence on a global level, though he left it unsaid whether the virus will help or hurt IBM's results in 2020.
Source Fool.com